Table 1.
Clinicopathologic characteristics of 40 patients.
| Variables | Number of cases | CXCL1 expression | High (n = 16) | P-value |
|---|---|---|---|---|
| Low (n = 24) | ||||
| Age (years) | ||||
| ≤65 | 21 | 14 | 7 | |
| >65 | 19 | 10 | 9 | 0.3656 |
| Gender | ||||
| Male | 24 | 15 | 9 | |
| Female | 16 | 9 | 7 | 0.6926 |
| Tumour position | ||||
| Bladder | 16 | 10 | 6 | |
| UTUC | 24 | 14 | 10 | 0.7921 |
| Pattern of progression | ||||
| Local recurrence | 9 | 8 | 1 | |
| Lymph node metastasis | 22 | 10 | 12 | |
| Visceral metastasis | 9 | 6 | 3 | 0.0730 |
| Lymph node metastasis | ||||
| Negative | 18 | 14 | 4 | |
| Positive | 22 | 10 | 12 | 0.0379* |
IHC immunohistochemistry, UTUC upper tract urothelial cancer.
*P < 0.05.